Home LiteratureArticle Details
PMID: 17898988 Published · ppublish English Journal Article Comment

The enteroinsular axis may mediate the diabetogenic effects of TCF7L2 polymorphisms.

Diabetologia ·Vol. 50 ·No. 12 ·2007-12-00 ·Pages 2413-6

Nauck MA, Meier JJ

Abstract

暂无摘要

MeSH Terms
Diabetes Complications/genetics Diabetes Mellitus/genetics Gastric Inhibitory Polypeptide/physiology Genetic Predisposition to Disease Glucagon-Like Peptide 1/physiology Humans Hyperglycemia/etiology,genetics Insulin/metabolism,physiology Insulin Secretion Intestinal Mucosa/metabolism Intestines/physiology Models, Biological Polymorphism, Single Nucleotide/physiology Signal Transduction/physiology TCF Transcription Factors/genetics,metabolism Transcription Factor 7-Like 2 Protein
Chemicals
Insulin TCF Transcription Factors TCF7L2 protein, human Transcription Factor 7-Like 2 Protein Gastric Inhibitory Polypeptide Glucagon-Like Peptide 1
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Nauck M A
Diabeteszentrum Bad Lauterberg, Kirchberg 21, D-37431, Bad Lauterberg, Harz, Germany. [email protected]
Meier J J
References (32)
32 references, click to expand
  1. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells.
    Endocrinology. 2002 Aug;143(8):3152-61 PMID: 12130581
  2. TCF7L2 variation predicts hyperglycemia incidence in a French general population: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.
    Diabetes. 2006 Nov;55(11):3189-92 PMID: 17065361
  3. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
    Endocrinology. 2003 Dec;144(12):5149-58 PMID: 12960095
  4. TCF7L2 and type 2 diabetes--we WNT to know.
    Diabetologia. 2007 Jan;50(1):5-7 PMID: 17102948
  5. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.
    Diabetes. 2003 Feb;52(2):380-6 PMID: 12540611
  6. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.
    Diabetes. 2006 Oct;55(10):2903-8 PMID: 17003360
  7. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.
    Nat Genet. 2006 Mar;38(3):320-3 PMID: 16415884
  8. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.
    Diabetologia. 2007 Dec;50(12):2443-50 PMID: 17661009
  9. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys.
    Horm Metab Res. 2007 Jan;39(1):46-52 PMID: 17226113
  10. Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women.
    Diabetes. 2006 Dec;55(12):3630-4 PMID: 17130514
  11. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
    N Engl J Med. 2006 Jul 20;355(3):241-50 PMID: 16855264
  12. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    J Clin Endocrinol Metab. 1993 Apr;76(4):912-7 PMID: 8473405
  13. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta.
    J Biol Chem. 2005 Jan 14;280(2):1457-64 PMID: 15525634
  14. Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans.
    Diabetes. 2007 May;56(5):1481-5 PMID: 17317761
  15. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Diabetes. 1996 Nov;45(11):1524-30 PMID: 8866556
  16. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).
    Nature. 1993 Jan 28;361(6410):362-5 PMID: 8381211
  17. TCF7L2: the biggest story in diabetes genetics since HLA?
    Diabetologia. 2007 Jan;50(1):1-4 PMID: 17096114
  18. Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.
    Diabetes Care. 2003 Mar;26(3):791-8 PMID: 12610039
  19. Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells.
    Endocrinology. 1992 Jan;130(1):159-66 PMID: 1309325
  20. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
    J Clin Invest. 2007 Aug;117(8):2155-63 PMID: 17671651
  21. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
    J Clin Invest. 1993 Jan;91(1):301-7 PMID: 8423228
  22. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses.
    J Clin Endocrinol Metab. 1986 Aug;63(2):492-8 PMID: 3522621
  23. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
    Lancet. 2006 Nov 11;368(9548):1696-705 PMID: 17098089
  24. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.
    J Clin Endocrinol Metab. 2001 Aug;86(8):3717-23 PMID: 11502801
  25. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells.
    Diabetologia. 2004 Mar;47(3):478-487 PMID: 14762654
  26. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Diabetologia. 2002 Aug;45(8):1111-9 PMID: 12189441
  27. The effects of glucagon-like peptide-I (GLP-I) on hormone secretion from isolated human pancreatic islets.
    Pancreas. 1995 Aug;11(2):196-200 PMID: 7479679
  28. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population.
    Diabetologia. 2007 Jan;50(1):63-7 PMID: 17093941
  29. TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population.
    Diabetes. 2007 Jul;56(7):1943-7 PMID: 17416797
  30. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.
    Diabetologia. 2007 Jun;50(6):1192-200 PMID: 17437080
  31. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals.
    Diabetes. 2006 Oct;55(10):2890-5 PMID: 17003358
  32. Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.
    Diabetologia. 2000 Jul;43(7):852-8 PMID: 10952457
Article Info
Journal
Diabetologia
Abbr.
Diabetologia
ISSN
0012-186X
DOI
10.1007/s00125-007-0832-8
Email
[email protected]
Published
2007-12-00
Pages
2413-6
Language
English
Region
Germany
NLM ID
0006777
Subset
IM
Corrections
CommentOn
PMID: 17661009
External Links
PubMed source DOI: 10.1007/s00125-007-0832-8 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2